Our clinicians use your health data, goals, and diagnostic results (like body composition and metabolic markers) to design a peptide protocol designed to your needs, whether for fat loss, recovery, or performance enhancement
It is not approved by the Therapeutic Goods Administration for human therapeutic use and is not a registered medicine
Melanotan-1 clearance is determined by its plasma half-life (4560 minutes) and enzymatic degradation rate both are fixed by molecular structure and unaffected by fluid intake beyond baseline renal health
Serious adverse effects are uncommon when dosing is appropriate and therapy is supervised, but ongoing monitoring and periodic labs are recommended to watch for shifts in glucose, fluid balance, or hormone sensitivity
Behind the scenes, however, is health care claims data that troubles us
The clinically useful combination is CJC-1295 plus Ipamorelin, where the second peptide acts on a different (ghrelin) pathway